文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹

大规模血清分析揭示银屑病与化脓性汗腺炎独特的系统性生物标志物

Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa.
PubMed 文献 · Br J Dermatol · 2021-10-21

该横断面研究采用Olink Explore高通量面板检测中重度化脓性汗腺炎(HS,n=11)、银屑病(n=10)及年龄和BMI匹配的健康对照(n=10)的1536种血清蛋白。结果显示HS循环蛋白失调更广泛,HS与对照有434种差异表达蛋白,银屑病与对照有138种,HS与银屑病之间有503种。两病Th1/Th17富集和IL-17A水平相当,但HS肿瘤坏死因子和IL-1β相关信号更强,Th17相关标志物PI3和LCN2可准确区分两病。

要点

  • HS血清炎症负荷高于银屑病,尽管银屑病体表面积受累更大。
  • HS与银屑病共享Th1/Th17富集和动脉粥样硬化相关蛋白升高。
  • PI3和LCN2可准确区分银屑病与HS。

核心结论

  • HS与银屑病共享显著Th1/Th17富集和动脉粥样硬化相关蛋白上调。
  • 尽管银屑病体表面积受累更大,HS呈现更高的血清炎症负荷。

研究设计与样本

  • 横断面研究,使用Olink Explore(邻近延伸分析)高通量面板评估1536种血清蛋白。
  • 纳入中重度HS患者(n=11)、银屑病患者(n=10)及年龄和体重指数匹配的健康对照(n=10)。

主要发现

  • HS与银屑病之间IL-17A水平和Th1/Th17通路富集相当。
  • HS呈现更强的肿瘤坏死因子和IL-1β相关信号。
  • Th17相关标志物PI3和LCN2能准确区分银屑病与HS。
  • 两病均呈现动脉粥样硬化相关蛋白升高,且临床严重度评分与免疫和动脉粥样硬化相关蛋白稳健相关。

关键数值与推荐

  • HS与对照差异蛋白434种,银屑病与对照138种,HS与银屑病之间503种。

临床怎么用

  • 血清PI3和LCN2有望作为区分银屑病与HS的生物标志物。
  • HS患者需关注系统性炎症负荷及动脉粥样硬化相关蛋白升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hidradenitis suppurativa (HS) is now recognized as a systemic inflammatory disease, sharing molecular similarities with psoriasis. Direct comparison of the systemic inflammation in HS with psoriasis is lacking. OBJECTIVES: To evaluate the serum proteome of HS and psoriasis, and to identify biomarkers associated with disease severity. METHODS: In this cross-sectional study, 1536 serum proteins were assessed using the Olink Explore (Proximity Extension Assay) high-throughput panel in patients with moderate-to-severe HS (n = 11), patients with psoriasis (n = 10) and age- and body mass index-matched healthy controls (n = 10). RESULTS: HS displayed an overall greater dysregulation of circulating proteins, with 434 differentially expressed proteins (absolute fold change ≥ 1·2; P ≤ 0·05) in patients with HS vs. controls, 138 in patients with psoriasis vs. controls and 503 between patients with HS and patients with psoriasis. Interleukin (IL)-17A levels and T helper (Th)1/Th17 pathway enrichment were comparable between diseases, while HS presented greater tumour necrosis factor- and IL-1β-related signalling. The Th17-associated markers peptidase inhibitor 3 (PI3) and lipocalin 2 (LCN2) were able to differentiate psoriasis from HS accurately. Both diseases presented increases of atherosclerosis-related proteins. Robust correlations between clinical severity scores and immune and atherosclerosis-related proteins were observed across both diseases. CONCLUSIONS: HS and psoriasis share significant Th1/Th17 enrichment and upregulation of atherosclerosis-related proteins. Despite the greater body surface area involved in psoriasis, HS presents a greater serum inflammatory burden.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Navrazhina K, Renert-Yuval Y, Frew JW, et al. Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa. Br J Dermatol. 2021. PMID: 34254293. doi:10.1111/bjd.20642

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。